SCIENTIFIC publications

/cun/en/investigacion/publicaciones-cientificas/areaMain/02
  • Randomized phase 3 study of carfilzomib or bortezomib with melphalan-prednisone for transplant-ineligible, NDMM patients

    Facon T (1), Lee JH (2), Moreau P (3), Niesvizky R (4), Dimopoulos M (5), Hajek R (6), Pour L (7), Jurczyszyn A (8), Qiu L (9), Klippel Z (10), Zahlten-Kumeli A (10), Osman M (10), Paiva B (11), San-Miguel J (11).

    (1) CHRU Lille Hopital Claude Huriez, Lille, France
    (2) Gachon University Gil Medical Center, Incheon, Korea, Republic of.
    (3) University of Nantes, Nantes, France.
    (4) Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, United States.
    (5) National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
    (6) University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
    (7) University Hospital Brno, Brno, Czech Republic.
    (8) Jagiellonian University, Krakow, Poland.
    (9) Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC State Key Lab of Experimental Hematology, Tianjin, China.
    (10) Amgen Inc., Thousand Oaks, CA, United States.
    (11) Clinica Universidad de Navarra-Centro de Investigacion Medica Aplicada, IDISNA, CIBERONC, Pamplona, Spain.

    Blood 28 FEBRUARY 2019

  • Risk of complications in patients with conservatively managed ovarian tumours (IOTA5)

    Froyman W (1), Landolfo C (2), De Cock B (3), Wynants L (3), Sladkevicius P (4), Testa AC (5), Van Holsbeke C (6), Domali E (7), Fruscio R (8), Epstein E (9), Dos Santos Bernardo MJ (10), Franchi D (11), Kudla MJ (12), Chiappa V (13), Alcazar JL (14), Leone FPG (15), Buonomo F (16), Hochberg L (17), Coccia ME (18), Guerriero S (19), Deo N (20), Jokubkiene L (4), Kaijser J (21), Coosemans A (22), Vergote I (22), Verbakel JY (23), Bourne T (24), Van Calster B (25), Valentin L (4), Timmerman D (26)

    (1) Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium.
    (2) Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Queen Charlotte's and Chelsea Hospital, Imperial College, London, UK.
    (3) Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
    (4) Department of Obstetrics and Gynecology, Skåne University Hospital Malmö, Lund University, Sweden.
    (5) Department of Woman and Child Health, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore Roma, Rome, Italy.
    (6) Department of Obstetrics and Gynecology, Ziekenhuis Oost-Limburg, Genk, Belgium.
    (7) First Department of Obstetrics and Gynecology, Alexandra Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
    (8) Clinic of Obstetrics and Gynecology, University of Milan-Bicocca, San Gerardo Hospital, Monza, Italy.
    (9) Department of Clinical Science and Education, Karolinska Institutet and Department of Obstetrics and Gynecology, Södersjukhuset, Stockholm, Sweden.
    (10) Department of Obstetrics and Gynecology, Centro Hospitalar Lisboa Central, Lisbon, Portugal.
    (11) Preventive Gynecology Unit, Division of Gynecology, European Institute of Oncology IRCCS, Milan, Italy.
    (12) Department of Perinatology and Oncological Gynecology, School of Health Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
    (13) Department of Gynecologic Oncology, National Cancer Institute of Milan, Milan, Italy.
    (14) Department of Obstetrics and Gynecology, Clinica Universidad de Navarra, School of Medicine, Pamplona, Spain.
    (15) Department of Obstetrics and Gynecology, Biomedical and Clinical Sciences Institute L. Sacco, University of Milan, Milan, Italy.
    (16) Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", Trieste, Italy.
    (17) Imaged Based Gynecology Service, Department of Obstetrics and Gynecology, University of South Florida Morsani College, Tampa, FL, USA.
    (18) Department of Obstetrics and Gynecology, University of Florence, Florence, Italy.
    (19) Department of Obstetrics and Gynecology, University of Cagliari, Policlinico Universitario Duilio Casula, Monserrato, Cagliari, Italy.
    (20) Department of Obstetrics and Gynaecology, Whipps Cross Hospital, London, UK.
    (21) Department of Obstetrics and Gynecology, Ikazia Hospital, Rotterdam, Netherlands.
    (22) Department of Oncology, Leuven Cancer Institute, Laboratory of Tumor Immunology and Immunotherapy, ImmunOvar Research Group, KU Leuven, Leuven, Belgium; Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium.
    (23) Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
    (24) Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium; Queen Charlotte's and Chelsea Hospital, Imperial College, London, UK.
    (25) Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, Netherlands.
    (26) Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium.

    Lancet Oncology 05 FEBRUARY 2019

  • Respiratory syncytial virus hospitalization in children in northern Spain

    Viguria N (1,2), Martínez-Baz I (2,3,4), Moreno-Galarraga L (1,2), Sierrasesúmaga L (5), Salcedo B (6), Castilla J (2,3,4).

    (1) Department of Pediatrics, Complejo Hospitalario de Navarra, Pamplona, Spain.
    (2) Instituto de Investigación Sanitaria de Navarra, IdiSNA, Pamplona, Spain.
    (3) Instituto de Salud Pública de Navarra, Pamplona, Spain.
    (4) CIBER Epidemiología y Salud Pública, Pamplona, Spain.
    (5) Clínica Universidad de Navarra, Pamplona, Spain.
    (6) Servicio de Gestión, Información y Evaluación, Complejo Hospitalario de Navarra, Pamplona, Spain.

    PLoS One 15 NOVEMBER 2018

  • Ratios of proteins in cerebrospinal fluid in Parkinson's disease cognitive decline

    Delgado-Alvarado M (1), Dacosta-Aguayo R (1,2), Navalpotro-Gómez I 1,2, Gago B (1,2), Gorostidi A (1,2,3), Jiménez-Urbieta H (1,2), Quiroga-Varela A (1,2,4), Ruiz-Martínez J (1,2,5), Bergareche A (1,2,5), Rodríguez-Oroz MC (1,2,4,5,6,7).

    (1) Neurodegenerative Disorders Area, Biodonostia Health Research Institute, San Sebastián, Spain.
    (2) Biomedical Research Networking Centre Consortium for the area of Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
    (3) Genomics Platform, Biodonostia Research Institute, San Sebastián, Spain.
    (4) Clinica Universidad de Navarra, Center for Applied Medical Research (CIMA)-Universidad de Navarra, Pamplona, Spain.
    (5) Movement Disorders Unit, Department of Neurology, University Hospital Donostia, San Sebastián, Spain.
    (6) Ikerbasque (Basque Foundation for Science), Bilbao, Spain.
    (7) Basque Center on Cognition Brain and Language (BCBL), San Sebastián, Spain.

    Movement Disorders 13 NOVEMBER 2018

  • Radioembolization versus chemoembolization for unresectable hepatocellular carcinoma

    Gardini AC (1), Tamburini E (2), Iñarrairaegui M (3), Frassineti GL (1), Sangro B (3).

    (1) Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
    (2) Department of Medical Oncology, Ospedale Infermi, Rimini, Italy.
    (3) Liver Unit, Clínica Universidad de Navarra-IDISNA and CIBEREHD, Pamplona, Spain.

    OncoTargets and Therapy 25 OCTOBER 2018

you mayBE INTERESTED

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra